PanoramicaGraficoNotizieSchermataTrader

BVT Aktienanleihe MOR 18.12.2024/  DE000VM6L1E6  /

Frankfurt Zert./VONT
23/05/2024  10:35:50 Var.-0.090 Denaro10:35:50 Lettera10:35:50 Sottostante Prezzo di esercizio Expiration date Tipo di opzione
104.510EUR -0.09% -
Quantità in denaro: -		 -
Quantità in lettera: -		 MORPHOSYS AG O.N. 13.66 - 18/12/2024 Call
GlobeNewswire 13:17 Howard Hughes Holdings Inc. to Present at NAREIT REITweek 2024 Investor Conference
GlobeNewswire 13:15 Draganfly to Present at Centurion One Los Angeles Summit 2024
GlobeNewswire 13:15 Ocugen to Present at BIO International Convention 2024
GlobeNewswire 13:15 The Habit Burger Grill Opens Second Lancaster Location in Home State of California
GlobeNewswire 13:02 Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire 13:00 Gildan Activewear Reports on Shareholders’ Voting Results
GlobeNewswire 13:00 Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
TeleTrader 13:00 US mortgage applications down 5.7%
GlobeNewswire 13:00 Host Hotels & Resorts Enters into Agreement to Acquire Turtle Bay Resort in Hawaii
GlobeNewswire 13:00 Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
GlobeNewswire 13:00 Lotus Technology Reports Unaudited First Quarter 2024 Financial Results
GlobeNewswire 13:00 Bitfarms Responds to Unsolicited Proposal from Riot Platforms
GlobeNewswire 13:00 Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Br...
GlobeNewswire 13:00 Cielo Announces Appointment of New Auditor
GlobeNewswire 13:00 Athira Pharma to Participate in Upcoming June Conferences
GlobeNewswire 13:00 Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, ...
GlobeNewswire 13:00 Dragonfly Energy to Participate in June 2024 Conferences
GlobeNewswire 13:00 Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezata...
GlobeNewswire 13:00 Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference
GlobeNewswire 13:00 Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 202...
GlobeNewswire 13:00 Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function ...
GlobeNewswire 13:00 Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabete...
GlobeNewswire 13:00 TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its ...
GlobeNewswire 13:00 Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 13:00 OTC Markets Group Welcomes Marpai, Inc. to OTCQX